» Articles » PMID: 22778413

A Plasmodium-encoded Cytokine Suppresses T-cell Immunity During Malaria

Overview
Specialty Science
Date 2012 Jul 11
PMID 22778413
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The inability to acquire protective immunity against Plasmodia is the chief obstacle to malaria control, and inadequate T-cell responses may facilitate persistent blood-stage infection. Malaria is characterized by a highly inflammatory cytokine milieu, and the lack of effective protection against infection suggests that memory T cells are not adequately formed or maintained. Using a genetically targeted strain of Plasmodium berghei, we observed that the Plasmodium ortholog of macrophage migration inhibitory factor enhanced inflammatory cytokine production and also induced antigen-experienced CD4 T cells to develop into short-lived effector cells rather than memory precursor cells. The short-lived effector CD4 T cells were more susceptible to Bcl-2-associated apoptosis, resulting in decreased CD4 T-cell recall responses against challenge infections. These findings indicate that Plasmodia actively interfere with the development of immunological memory and may account for the evolutionary conservation of parasite macrophage migration inhibitory factor orthologs.

Citing Articles

Malaria blood stage infection suppresses liver stage infection via host-induced interferons but not hepcidin.

Patel H, Minkah N, Kumar S, Zanghi G, Schepis A, Goswami D Nat Commun. 2024; 15(1):2104.

PMID: 38453916 PMC: 10920859. DOI: 10.1038/s41467-024-46270-3.


The Role of Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (D-DT/MIF-2) in Infections: A Clinical Perspective.

Breidung D, Megas I, Freytag D, Bernhagen J, Grieb G Biomedicines. 2024; 12(1).

PMID: 38275363 PMC: 10813530. DOI: 10.3390/biomedicines12010002.


Cytokine profiles in adults with imported malaria.

de Roquetaillade C, Laouenan C, Mira J, Roy C, Thuong M, Azoulay E Sci Rep. 2023; 13(1):10347.

PMID: 37365194 PMC: 10293253. DOI: 10.1038/s41598-023-36212-2.


Deletion of MIF gene from live attenuated LdCen parasites enhances protective CD4 T cell immunity.

Fiuza J, Gannavaram S, Gaze S, de Ornellas L, Alves E, Ismail N Sci Rep. 2023; 13(1):7362.

PMID: 37147351 PMC: 10163264. DOI: 10.1038/s41598-023-34333-2.


-encoded murine IL-6 impairs liver stage infection and elicits long-lasting sterilizing immunity.

Belhimeur S, Briquet S, Peronet R, Pham J, Commere P, Formaglio P Front Immunol. 2023; 14:1143012.

PMID: 37143657 PMC: 10152192. DOI: 10.3389/fimmu.2023.1143012.


References
1.
Thera M, Plowe C . Vaccines for malaria: how close are we?. Annu Rev Med. 2011; 63:345-57. PMC: 3338248. DOI: 10.1146/annurev-med-022411-192402. View

2.
Griffith J, OConnor C, Bernard K, Town T, Goldstein D, Bucala R . Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis. 2007; 196(10):1553-64. DOI: 10.1086/522865. View

3.
Scharton-Kersten T, Afonso L, Wysocka M, Trinchieri G, Scott P . IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 1995; 154(10):5320-30. View

4.
Yoshimoto T, Takahama Y, Wang C, Yoneto T, Waki S, Nariuchi H . A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J Immunol. 1998; 160(11):5500-5. View

5.
Li J, Huston G, Swain S . IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med. 2003; 198(12):1807-15. PMC: 2194161. DOI: 10.1084/jem.20030725. View